IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: George C. Grasser who wrote (61)	4/24/1997 2:35:00 PM
From: Mark B. Martell, CCM	of 1510

Agreed George. I'm just kind of curious about the possibility of a cure. If they receive great indicators for Remune in fighting Aids, they may be able to rush the compound to market through the FDA. With Merck and Glaxo seemingly on board to co-market in a cocktail approach, strong sales could ensue. I'd like to hear more about Remune, along with discussion as to why the owners are beefing up their position in the stock. Blue Horse relayed that there was a report available which provides a bullish outlook on the drug. Like others, I'm wondering as to what Blue is talking about. I'd certainly like to hear more discussion about this stock on this thread. This could be an interesting company to follow over the next several months. Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next